NextCure Inc reports results for the quarter ended in September - Earnings Summary

NextCure

04/11/2022 03:05

* NextCure Inc  NXTC.OQ  reported a quarterly adjusted loss
of 68
cents​​ per share for the quarter ended in September. The mean
expectation of seven analysts for the quarter was for a loss
of 63 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * NextCure Inc's reported EPS for the quarter was a loss
of 68
cents​.
    * The mean earnings estimate of analysts had risen by
about 5% in
the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * NextCure Inc shares had fallen by 10.2% this quarter and
lost 58.8% so far this year.
    * The company reported a quarterly loss of $18.91 million.
    * Wall Street's median 12-month price target for NextCure
Inc is
$9.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
4 at 03:05 a.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.63          -0.68          Missed
 Jun. 30 2022      -0.72          -0.65          Beat
 Mar. 31 2022      -0.67          -0.74          Missed
 Dec. 31 2021      -0.67          -0.61          Beat